Citation
Ahmed, T. A. H. N. (2011, December 15). Innovative therapies for optimizing outcomes of coronary artery disease. Retrieved from
https://hdl.handle.net/1887/18249
Version: Corrected Publisher’s Version
License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden
Downloaded from: https://hdl.handle.net/1887/18249
Note: To cite this publication please use the final published version (if applicable).
Innovative therapies for optimizing outcomes of coronary artery disease
Tarek A.N. Ahmed
ISBN: 978-94-6169-183-5
Financial support to the costs associated with the publication of this thesis from the depart- ment of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.
Tarek Ahmed bw.indd 2
Tarek Ahmed bw.indd 2 15-11-11 18:0415-11-11 18:04
Innovative therapies for optimizing outcomes of coronary artery disease
PROEFSCHRIFT
ter verkrijging van
de graad van Doctor aan de Universiteit Leiden, op gezag van de Rector Magnifi cus prof. mr. P.F. van der Heijden,
volgens besluit van het College voor Promoties
te verdedigen op donderdag 15 December 2011 klokke 15:00 uur
door
Tarek Abdel-Hameed Nagib Ahmed Geboren te Asyut, Egypte
1976
Dr. H.F. Verwey Dr. B.L. van der Hoeven
Dr. S.A.M. Said, Ziekenhuis Groep Twente, Hengelo
Tarek Ahmed bw.indd 4
Tarek Ahmed bw.indd 4 15-11-11 18:0415-11-11 18:04
To Heba and Ayah
CONTENTS OF THE THESIS
Chapter 1: General introduction and outline of the thesis. 9
Chapter 2: Aspiration thrombectomy during primary percutaneous coronary inter- vention as adjunctive therapy to early (in-ambulance) abciximab administration in patients with acute ST elevation myocardial infarction: An analysis from Leiden MIS- SION! Acute Myocardial Infarction Treatment Optimization Program.
Journal of Interventional Cardiology 2011 Nov 8 [Epub ahead of print]
27
Chapter 3: Pre-infarction angina predicts thrombus burden in patients admitted for ST-segment elevation myocardial infarction.
Submitted for publication
47
Chapter 4: Clinical performance of drug eluting stents with Biodegradable polymeric coating, a meta-analysis and systematic review.
EuroIntervention 2011; Aug; 7(4):505-16
67
Chapter 5: Emerging drugs for coronary artery disease. From past achievements and current needs to clinical promises.
Expert Opinion on Emerging Drugs. 2011 Jun; 16(2):203-233.
89
Chapter 6: Restenosis after PCI- Part II: Prevention and therapy.
Nature Reviews Cardiology 2011 Oct 11[Epub ahead of print]
145
Chapter 7: Late stent malapposition in the bare metal stent and drug eluting stent era.
Book Chapter In: Coronary Stent Restenosis (eds. Tintoiu IC, Popma JJ, Bae J-H, Rivard A, Galassi AR, Gabrie C. – Bucharest: The Publishing House of the Romanian Academy, 2011, ISBN 978-973-27-2034-9. Chapter 16)
173
Chapter 8: Summary, conclusions and future perspectives. 187
Chapter 9: Samenvatting, conclusies en toekomstperspectief. 195
Acknowledgement 205
Curriculum Vitae 209
List of Publications 215
